3
After a heart attack, 44% of patients quit treatment, risking another attack – study by RUDN University scientists

After a heart attack, 44% of patients quit treatment, risking another attack – study by RUDN University scientists

Researchers at the RUDN Institute of Medicine and Moscow City Polyclinic No. 2 analyzed how patients after acute myocardial infarction comply with recommendations for dual antiplatelet therapy (DAPT) – a combination of acetylsalicylic acid (ASA) and a P2Y12 inhibitor (ticagrelor, clopidogrel, or prasugrel). The work was awarded first place in the LekBez 2025 competition for young scientists in the field of drug safety at the Third Russian Congress “Pharmacotherapy Safety 360°: Noli nocere!”

The study covered 168 patients who demonstrated high adherence to dual antiplatelet therapy in the first 6 months after myocardial infarction and assessed how their behavior changed over the course of a year, as well as the correlation between adherence, haemorrhagic complications of therapy and the risk of recurrent cardiovascular events.

After a myocardial infarction, DAPT is critical for preventing recurrent heart attacks. However, according to the study results, 43.5% of patients stopped adhering to their treatment regimen in the second half of the year, despite subsidized medication in Moscow. 24.4% of patients experienced hemorrhagic complications (bleeding), which forced them to adjust or discontinue treatment on their own. An additional problem was the rare use of the PRECISE-DAPT scale by doctors to predict bleeding, although in 22.6% of patients this risk was found to be high in the study assessment. These circumstances lead to a dilemma: discontinuing DAPT reduces the number of bleeds but increases the risk of recurrent heart attacks. For example, in non-adherent patients, hospitalizations due to cardiac complications in the second half of the year were more than three times more frequent than in those who continued therapy.

“Solving this problem requires a comprehensive approach. First and foremost, it is necessary to implement monitoring of treatment adherence through the use of electronic prescriptions. This will allow doctors to track the degree of patient compliance with therapy in real time and adjust prescriptions in a timely manner. In addition, an individual approach to therapy adjustment is necessary. For example, in cases of mild bleeding, it is advisable to temporarily reduce the dose of acetylsalicylic acid (19.5% of cases) or replace ticagrelor with clopidogrel (9.8%). For patients at high risk of bleeding according to the PRECISE-DAPT scale, international guidelines recommend reducing the duration of DAPT to 3–6 months. Implementing continuous education among both patients and healthcare professionals is equally important. Patients need to be informed about the risks associated with discontinuing therapy, and physicians need to be informed about the importance of using modern bleeding risk assessment scales to prescribe the right personalized treatment,” Dmitry Klyuev, assistant professor in the Department of General and Clinical Pharmacology at the RUDN University Institute of Medicine.

The study was conducted by a research team at RUDN University. Co-authors include:

  • Sergey Fitilov, Professor, Department of General and Clinical Pharmacology;
  • Irina Shkrebneva, Associate Professor, Department of General and Clinical Pharmacology;
  • Alexander Vozzhaev, Professor, Department of General and Clinical Pharmacology;
  • Anna Ovaeva, Assistant, Department of General and Clinical Pharmacology.
International Projects View all
Student's Scientific Initiatives View all
03 Nov 2017
June 22 - 26, 2017 in Barnaul, Altai State University, took place the Summer Academy of the BRICS Youth Assembly, an international event that brought together representatives of different countries
2379
Similar newsletter View all
28 Nov
To chip the placenta. RUDN University researcher wins a competition for young scientists with a cell model

The project to develop a cellular model of the placenta became the winner in the Scientific Materials category of the Young Scientists 3.0 competition, organized with the support of the Presidential Grants Foundation and T-Bank.

12
28 Nov
The White List: 10 scientific journals from RUDN University have been included in the first highest level of the state list of scientific publications

Ten scientific journals published by RUDN University have been included in the highest level of the state list of scientific publications, the White List.

14
28 Nov
The role of fungi in maintaining tree diversity has been unraveled – a global study involving scientists from RUDN University

Forests are not only the lungs of the planet, but also home to millions of species. However, it has remained unclear how underground interactions between trees and fungi affect forest species richness in different climatic conditions. Previous studies have yielded conflicting results: in some regions, the dominance of certain fungi reduced tree diversity, while in others it increased it.

13
Similar newsletter View all